PKD1 and cancer: Extensive studies of functional changes in cell and tissue organization in the context of ADPKD have demonstrated an extremely pleiotropic activity, in which mutations reducing PKD1 expression or function produce phenotypes similar to those observed in tumors and described as the “hallmarks of cancer”, albeit typically in attenuated form [56].